Surgery Partners Q2 revenue up 13.3% to $615.4M; Adj EBITDA up 13.4% to $86.1M

Surgery Partners, Inc.

2022-Q2 EPS reported -$0.07 revenue$1,211,600,000

Revenue $615.4M vs $543.3M; net loss $18.4M vs $26.9M in prior year quarter.
Days adjusted same-facility revenues up 6.9%; cases +1.9%, revenue per case +4.9%.
Adj EBITDA ex-CARES grants up 17.8% to $86.0M; margin 14.0%.
2022 guidance reaffirmed: revenue $2.5-2.6B, Adj EBITDA $375-385M.
Deployed ~$90M in six acquisitions at ~7x average multiple; liquidity $227.4M cash plus $203M revolver.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.